Inflammatory phenotypes in severe pneumonia: clinical evidence to mouse models for precision therapeutics
American Journal of Respiratory and Critical Care Medicine · 01.11.2026 · 212 (11) · 2792-2802
DOI: 10.1093/ajrccm/aamag402 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Respiratory and Critical Care Medicine, online erschienen am 31.07.2026. Verfasst von Hiroki Taenaka und 26 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular Research Institute, University of California, San Francisco, CA, United States. Hauptthemen laut MEDLINE: Precision Medicine, Inflammation, Pneumonia, Pneumococcal, Pneumonia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI, Marumo Emergency Medicine Research Promotion Public Trust, NHLBI NIH HHS.
Abstract (Originalsprache)
Rationale
Hyperinflammatory and hypoinflammatory phenotypes previously identified in sepsis and acute respiratory distress syndrome may enable precision therapies, but their clinical relevance and translational modeling in severe pneumonia remain incompletely characterized.
Objectives
To examine biomarker-defined hyperinflammatory and hypoinflammatory phenotypes in critically ill patients with pneumonia (pulmonary sepsis), test whether the biomarkers that define these phenotypes identify subgroups and outcomes in a mouse model of bacterial pneumonia, and determine whether the mouse phenotypes respond differently to therapeutic interventions.
Methods
We performed latent class analysis (LCA) in a cohort of 548 ICU patients with pulmonary sepsis to identify inflammatory phenotypes and test the association of these phenotypes with clinical outcomes using validated classifier models. We developed a mouse model of pneumococcal pneumonia that recapitulated key aspects of these phenotypes and tested responses to dexamethasone and IL-6 receptor blockade. Measurements and Main Results Two phenotypes were identified in patients with pulmonary sepsis: a hyperinflammatory phenotype with more lung injury and increased mortality, and a hypoinflammatory phenotype with more favorable outcomes. Despite uniform pathogen exposure and baseline conditions, LCA identified 2 phenotypes in the mice with divergent trajectories (lung injury and mortality). Therapeutic benefit from anti-inflammatory interventions was observed exclusively in the more inflamed mice.
Conclusions
By integrating clinical data from human studies and experimental findings in a clinically relevant mouse model, this study provides a translational framework for developing phenotype-targeted therapies for critical illness, with the goal of improving patient outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cardiovascular Research Institute, University of California, San Francisco, CA, United States.
- Department of Anesthesiology and Intensive Care Medicine, Osaka University Graduate School of Medicine, Suita, Japan.
- Inserm CIC 1435, Dupuytren Teaching Hospital, Limoges, France.
- Department of Medicine, University of California, San Francisco, CA, United States.
- Department of Anesthesia, Cardiovascular Research Institute, University of California, San Francisco, CA, United States.
ORCID-Profile: Aartik Sarma, Natasha Spottiswoode, Kathryn M Sullivan
Förderung
- NHLBI
- Marumo Emergency Medicine Research Promotion Public Trust
- NHLBI NIH HHS
- NHLBI HL
- NIAAA NIH HHS
- "La Société de Réanimation de Langue Française," "Association Limousine d'Aide aux Insuffisants Respiratoires," "Philippe Fondation," and "L'institut Servier
- “La Société de Réanimation de Langue Française,” “Association Limousine d’Aide aux Insuffisants Respiratoires,” “Philippe Fondation,” and “L’institut Servier
Zitieren
APA
Taenaka, H., Evrard, B., Maishan, M., Watanabe, R., Alipanah-Lechner, N., Carrillo, S. A., Sarma, A., Spottiswoode, N., Sullivan, K. M., Weingart, M. F., Zhuo, H., Ringor, A., Leroux, C., Chao, O., Lin, C., Schmiege, E., Hariharan, T., Magee, L., Willmore, A., …, & Matthay, M. A. (2026). Inflammatory phenotypes in severe pneumonia: clinical evidence to mouse models for precision therapeutics. American Journal of Respiratory and Critical Care Medicine, 212(11), 2792-2802. https://doi.org/10.1093/ajrccm/aamag402
Vancouver
Taenaka H, Evrard B, Maishan M, Watanabe R, Alipanah-Lechner N, Carrillo SA, et al. Inflammatory phenotypes in severe pneumonia: clinical evidence to mouse models for precision therapeutics. American Journal of Respiratory and Critical Care Medicine. 2026;212(11):2792-2802. doi:10.1093/ajrccm/aamag402
BibTeX
@article{Taenaka2026,
author = {Taenaka, Hiroki and Evrard, Bruno and Maishan, Mazharul and Watanabe, Ruriko and Alipanah-Lechner, Narges and Carrillo, Sidney A and Sarma, Aartik and Spottiswoode, Natasha and Sullivan, Kathryn M and Weingart, Melanie F and Zhuo, Hanjing and Ringor, Angelika and Leroux, Carolyn and Chao, Olivia and Lin, Chelsea and Schmiege, Emma and Hariharan, Taarini and Magee, Liam and Willmore, Andrew and Chak, Suzanna and Lee, Deanna and Bardillon, Kim and Hendrickson, Carolyn and Gotts, Jeffrey E and Langelier, Charles R and Calfee, Carolyn S and Matthay, Michael A},
title = {Inflammatory phenotypes in severe pneumonia: clinical evidence to mouse models for precision therapeutics},
journal = {American Journal of Respiratory and Critical Care Medicine},
year = {2026},
volume = {212},
number = {11},
pages = {2792--2802},
doi = {10.1093/ajrccm/aamag402}
}
EUVIMED